The Role of Monoclonal Antibodies in the Management of Leukemia by Mohamad Cherry, Aref Al-Kali, Ali Al-Ameri, Alessandra Ferrajoli

Get full text

Determinants of survival and retrospective comparisons of 183 clinical trial patients with myelofibrosis treated with momelotinib, ruxolitinib, fedratinib or BMS- 911543 JAK2 inhib... by Naseema Gangat, Kebede H. Begna, Aref Al-Kali, William Hogan, Mark Litzow, Animesh Pardanani, Ayalew Tefferi

Get full text

Busulfan Treatment for Myeloproliferative Disease may Reduce Injection Burden in Vascular Endothelial Growth Factor-Driven Retinopathy by Lauren A. Dalvin, Timothy W. Olsen, Sophie J. Bakri, Kristen McCullough, Ayalew Tefferi, Aref Al-Kali

Get full text

A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome by Jehad Almasri, Hassan B. Alkhateeb, Belal Firwana, Mohamad Bassam Sonbol, Moussab Damlaj, Zhen Wang, M. Hassan Murad, Aref Al-Kali

Get full text

Erythrocytosis associated with <i>EPAS1</i>(<i>HIF2A</i>), <i>EGLN1</i>(<i>PHD2</i>), <i>VHL, EPOR</i> or <i>BPGM</i> mutations: The Mayo Clinic experience by Naseema Gangat, Jennifer L. Oliveira, Tavanna R Porter, James D. Hoyer, Aref Al-Kali, Mrinal M. Patnaik, Animesh Pardanani, Ayalew Tefferi

Get full text

Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients by Aref Al-Kali, Sergej Konoplev, Erpei Lin, Tapan Kadia, Stefan Faderl, Farhad Ravandi, Mohamad Ayoubi, Mark Brandt, Jorge E. Cortes, Hagop Kantarjian, Gautam Borthakur

Get full text

Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant by Ayalew Tefferi, Animesh Pardanani, Kebede H. Begna, Aref Al-Kali, William J. Hogan, Mark R. Litzow, Rhett P. Ketterling, Kaaren K. Reichard, Naseema Gangat

Get full text

One thousand patients with essential thrombocythemia: the Mayo Clinic experience by Naseema Gangat, Omer Karrar, Aref Al-Kali, Kebede H. Begna, Michelle A. Elliott, Alexandra P. Wolanskyj-Spinner, Animesh Pardanani, Curtis A. Hanson, Rhett P. Ketterling, Ayalew Tefferi

Get full text

S263: CYTOPENIAS, AGE AND CAR-HEMATOTOX SCORE PREDICT THE DEVELOPMENT OF POST CAR T-CELL THERAPY-RELATED MYELOID NEOPLASMS by Mark Gurney, Hassan Alkhateeb, Syed Shah, Radhika Bansal, Matthew Hathcock, Allison Rosenthal, Mohamed Kharfan-Dabaja, Taxiarchis Kourelis, Mrinal Patnaik, Dong Chen, Aref Al-Kali, Saad Kenderian, Yi Lin, Mithun Shah

Get full text

Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia by Naseema Gangat, Isla Johnson, Kristen McCullough, Faiqa Farrukh, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Abhishek Mangaonkar, Mark Litzow, William Hogan, Mithun Shah, Mrinal Patnaik, Animesh Pardanani, Ayalew Tefferi

Get full text

Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs by Ahmad Ghorab, Aref Al-Kali, Michelle Elliot, Naseema Gangat, Hasan Alkhateeb, Mithun Shah, Yuanhang Liu, Cecilia Arana Yi, Hemant Murthy, Mohamed Kharfan-Dabaja, Ayalew Tefferi, Mrinal Patnaik, Mark Litzow, Talha Badar

Get full text

Dedifferentiation of B-lymphoblastic leukemia/lymphoma with t(9;22) BCR::ABL1 to an undifferentiated neoplasm with strong keratin expression in a patient receiving blinatumomab by Krasimira A. Rozenova, Anja C. Roden, Christopher Hartley, Jess F. Peterson, Gregory E. Otteson, Aref Al-Kali, Harry E. Fuentes Bayne, Mithun V. Shah, Mrinal S. Patnaik, Rebecca L. King, Daniel P. Larson

Get full text

Isolated anemia in patients with large granular lymphocytic leukemia (LGLL) by Youssef Salama, Fang Zhao, Jennifer L. Oliveira, Ji Yuan, Dragan Jevremovic, Ronald S. Go, Wei Ding, Sameer A. Parikh, Mithun V. Shah, Paul J. Hampel, Aref Al-Kali, William G. Morice, Min Shi

Get full text

Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapy by Zhuoer Xie, Terra Lasho, Arushi Khurana, Alejandro Ferrer, Christy Finke, Abhishek A. Mangaonkar, Stephen Ansell, Jenna Fernandez, Mithun Vinod Shah, Aref Al-Kali, Naseema Gangat, Jithma Abeykoon, Thomas E. Witzig, Mrinal M. Patnaik

Get full text

Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy by Naseema Gangat, Rimal Ilyas, Isla M Johnson, Kristen McCullough, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek Mangaonkar, Mark R Litzow, William Hogan, Mithun Shah, Mrinal M Patnaik, Animesh Pardanani, Ayalew Tefferi

Get full text

DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation by Majd Jawad, Michelle Afkhami, Michelle Afkhami, Yi Ding, Xiaohui Zhang, Peng Li, Kim Young, Mina Luqing Xu, Wei Cui, Yiqing Zhao, Stephanie Halene, Aref Al-Kali, David Viswanatha, Dong Chen, Rong He, Gang Zheng, Gang Zheng

Get full text

Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study by Zhuoer Xie, Ahmad Nanaa, Antoine N. Saliba, Rong He, David Viswanatha, Phuong Nguyen, Dragan Jevremovic, Patricia Greipp, Mohamad E. Salama, Naseema Gangat, Hassan B. Alkhateeb, Ayalew Tefferi, Mark Litzow, Mrinal Patnaik, Mithun Shah, Aref Al-Kali

Get full text

Molecular predictors of response and survival in patients with relapsed/refractory acute myeloid leukemia following venetoclax plus hypomethylating agent therapy by Isla M. Johnson, Rimal Ilyas, Kristen McCullough, Aref Al-Kali, Hassan B. Alkhateeb, Kebede H. Begna, Abhishek Mangaonkar, Antoine Saliba, Mark R. Litzow, William Hogan, Mithun Shah, Mrinal M. Patnaik, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat

Get full text

P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE by Rami Basmaci, Anmol Baranwal, Rong He, David Viswanatha, Patricia Greipp, James M Foran, Cecilia Arana Yi, Mithun Shah, Abhishek Mangaonkar, Mark Litzow, William Hogan, Kebede Benga, Antoine Saliba, Naseema Gangat, Ayalew Tefferi, Mrinal Patnaik, Aref Al-Kali, Hassan Alkhateeb

Get full text

Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience by Ayalew Tefferi, Naseema Gangat, Mithun Shah, Hassan Alkhateeb, Mrinal S. Patnaik, Aref Al-Kali, Michelle A. Elliott, William J. Hogan, Mark R. Litzow, Christopher C. Hook, Abhishek Mangaonkar, David Viswanatha, Dong Chen, Animesh Pardanani, Rhett P. Ketterling, Kebede H. Begna

Get full text